Affluent Partners Holdings' (HKG:1466) subsidiary Beijing Baijin Biotechnology agreed to cooperate with Hangzhou Changwei Hospital to establish a smart medical service model with specialized expertise and treatment, a Wednesday filing with the Hong Kong Exchange said.
The parties will utilize their complementary advantages to create a smart medical service system which will cover medical treatment, teaching, and scientific research.
The service model will include a smart medical information system, specialty and disease-based treatment and management smart medical service platforms, and a specialty-specific smart medical management system.
The Jewelry maker and trader's shares were up 14% on Wednesday's close.
Price (HKD): $0.57, Change: $+0.070, Percent Change: +14.00%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。